-
Patents Against People: How Drug Companies Price Patients out of Survival – Courtesy (Dissent)
As our television screens toggle between pundits squabbling over Obamacare’s insurance rules and ads for erectile dysfunction remedies, another...
-
Merck scores victory in India patent battle over top diabetes meds! – Courtesy (Fierce Pharma)
In a potentially promising sign for Western drugmakers, Merck ($MRK) scored a victory in its patent battle with India’s Glenmark...
-
First Look At False Marking Under The AIA – Courtesy (Pharma Patents)
POSTED BY COURTENAY C. BRINCKERHOFF ON 14 MAY 2015POSTED IN FEDERAL CIRCUIT DECISIONSIn Sukumar v. Nautilus, Inc., the Federal Circuit took its first...
-
Brand owners file packaging patents – Courtesy (Packaging Digest)
Wm. Bolthouse Farms, Inc., Bakersfield, CA, inventive container permits point-of-use mixing of separate, compartmentalized ingredients without rupturing the main...
-
FDA To Give 5 Year NCE Exclusivity To Combinations – Courtesy (Pharma Patents)
POSTED BY COURTENAY C. BRINCKERHOFF ON 26 FEBRUARY 2014POSTED IN FDAIn a Federal Register Notice dated February 24, 2014, the U.S. FDA announced a...
-
Big stakes on drug patents! -By Dean Baker
Last fall, India’s new Prime Minister, Narendra Modi, met with President Obama in Washington. According to the public accounts,...
-
Louisiana Challenge’s AstraZeneca on Antitrust Claims for Asserting Invalid Drug Patents – Courtesy(PATENTLYO)
In March 2015, the state of Louisiana filed suit against AstraZeneca alleging antitrust violations based upon the company’s actions of...
-
Drug patents are Bad for your health: the cost of mismarketing – By Dean Baker
The rationale for granting patents for new drugs is to give companies incentives to research new and better drugs....
